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Recently, we  have  been  studying the  regulation of cytotoxic lymphocyte  (CTL) 
responses  in  NZB  mice.  These  studies  have  demonstrated  that  NZB  CTL  were 
relatively resistant to suppressor signals (1). In the present paper, we studied the time- 
course of generation and the kinetics of lysis of CTL from nonprimed BALB/c, DBA/ 
2, NZB, and alloantigen-primed BALB/c and NZB spleen cells in allogeneic mixed 
leukocyte  cultures.  These  investigations  suggested  that  NZB  spleen  cells  have  an 
accelerated  generation  of primary  CTL  responses,  which,  in  some  respects,  mimic 
secondary CTL  responses of alloantigen-primed mice. These observations shed light 
on recent reports of abnormal recognition phenomena by NZB T  cells (2-4). 
Materials and  Methods 
Mice.  Female mice were used in all experiments. BALB/c (H-2  d) and NZB/N (H-2  o) mice 
were obtained from the breeding colonies of the National Institutes of Health, Bethesda, Md. 
DBA/2J (H-2  d) and C57BL/6J  (B6) (H-2  b) mice were obtained from The Jackson Laboratory, 
Bar Harbor, Maine. 
Alloantigen Sensitization In  Vivo.  Mice were sensitized by injection of 1 ×  107 B6 spleen cells, 
in  0.05  ml  of Hanks'  balanced  salt  solution  (HBSS),  into  each  hind  footpad.  After  14  d, 
sensitized mice were sacrificed by cervical dislocation, and their spleens were removed under 
aseptic conditions. Single spleen-cell suspensions were prepared by gentle teasing in HBSS. The 
spleen cells were either assayed for CTL activity or were used as primed responder cells in in 
vitro mixed leukocyte cultures (MLC). 
MLC.  Single spleen-cell suspensions were prepared in HBSS from in vivo primed mice and 
from nonprimed mice. B6 spleen cells, to be used as in vitro stimulator cells, were exposed to 
1,500 rad of gamma irradiation. Cells were cultured in modified Eagle's minimum essential 
medium  (MEM)  with  10%  heat-inactivated, mycoplasma-screened fetal  calf serum  (FCS) 
(Grand Island Biological Co., Grand Island, N. Y.), in 16-mm, flat-bottom culture wells (Cost  ar, 
Data Packaging,, Cambridge, Mass.). 6-24  replicate wells that  contained  1 ×  107 responder 
cells and 1 X  10  irradiated stimulator cells were cultured in a final vol of 1.5 ml. Cultures were 
incubated for the specified number of days in a  humidified atmosphere of 10% CO2,  7% 02, 
and 83% N2 at 37°C. 
Preparation of Target Cells.  EL-4  tumor  cells were  maintained  by  weekly intraperitoneal 
7  passage  in  B6  female  mice.  2  ×  i0  tumor  cells  were  incubated  with  100  #Ci  of 51Cr 
(Na2[  Cr]Oa, 200-500 Ci/g Cr sp act; New England Nuclear, Boston, Mass.) in 1 ml of HBSS 
with  10%  FCS  for 30  min  at  37°C.  The  labeled target cells were  then  washed  three  times 
through 2 ml of FCS at 250 g for  10 rain and diluted in MEM with  10% FCS to the desired 
concentration. 
Cell-mediated Lympholysis Assay.  Cytotoxicity was assayed as previously described (1). Effector 
cells were washed and  resuspended in  MEM  with  10%  FCS to the desired concentration of 
viable cells, and  mixed with equal  volumes  (0.1 ml)  of 51Cr-labeled target cells in serologic 
tubes.  Effector and  target cells were incubated  for indicated times up  to 4  h  at  37°C  in  a 
humidified atmosphere with 5% CO2;  radioactivity released into the supernate was measured 
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in a  gamma spectrometer  (model 8000;  Beckman Instruments,  Inc., Spinco Div., Palo Alto, 
Calif.).  Each determination was assayed in duplicate. Spontaneous 51Cr release was determined 
by incubating 0.1 ml of target cells with 0.1 ml of MEM with 10% FCS. Maximum release  was 
determined by three cycles of freezing and thawing similar cultures. Spontaneous release was 
determined  for each time-point in an assay.  Data from 4-h fixed-end-point experiments  are 
expressed as percent specific lysis and were calculated by the formula: 
experimental release  -  spontaneous release 
percent specific  lysis =  100 X 
maximum release  -  spontaneous release 
Data from multiple-end-point  experiments are expressed as the number of target cells killed 
and were calculated by the formula: 
No. of target cells killed  =  percent specific  lysis ×  number of target cells used in assay. 
Analysis of Multiple-Time-Point Kinetic Data.  The initial reaction velocities  were determined 
directly from the slope of the plot of three data points within the 1st 90 min of the cytotoxicity 
assays.  Each data point represented the mean of duplicate determinations; the standard error 
from the mean for each data point was <t%. The percent target cells killed in the initial 90 min 
of the cytotoxicity assays was determined from the slope of the plot of the initial velocity of lysis 
vs. the number of target cells used in the assay and were calculated by the formula: 
100 ×  number of target cells killed 
percent target cells killed =  +  time =  100 X slope. 
number of target cells used in assay 
Linear regression  correlation coefficients for the fit of the experimentally determined points to 
a straight line were between 0.96 and 0.99. 
Results 
Comparison  of the  Time-Course of Generation of BALB/c,  DBA/2,  and  NZB  CTL. 
BALB/c, DBA/2, and NZB spleen  cells were stimulated  in vitro with  irradiated  B6 
spleen cells for 2, 4, or 6 d  before assaying for anti-EL-4 CTL activity. BALB/c and 
DBA/2 CTL activity was first detected on day 4 and increased markedly by day 6. In 
contrast, initial NZB CTL activity was noted on day 2, markedly increased by day 4, 
and  declined slightly  by day 6  (Fig.  1).  Similar  CTL response curves were demon- 
strated with spleen cells from 1- and 6-mo-old NZB mice in three experiments.  These 
primary  NZB  CTL  response  curves  differed  from  those  of primary  BALB/c  and 
DBA/2 CTL but  were similar  to the secondary CTL response curves of spleen  cells 
from primed  BALB/e mice  (Fig.  1).  Moreover, primary NZB CTL response curves 
were also similar  to the secondary CTL response curves of spleen  cells from primed 
NZB mice (Fig.  1). 
Analyses of BALB/c, DBA/  2, and NZB CTL Kinetics of Lysis after 4 and 6 d in MLC.  To 
further compare the CTL responses, kinetic analyses were performed during the initial 
90  min  of the  51Cr-release  assays.  Nonprimed  BALB/c,  DBA/2,  and  NZB,  and 
alloantigen-primed  BALB/c and NZB, spleen cells were cultured with irradiated  B6 
spleen  cells  for 4  and  6  d.  From these CTL responses,  initial  reaction  velocities  (Vi) 
were determined. A plot of the Vi (number of target lysed/h) against the corresponding 
initial  target-cell number showed a  linear dose-dependent  relationship  (Fig. 2). From 
the slope of these lines, the percent target cells lysed in the initial 90 min of assay (i.e., 
efficiencies  of lysis)  was  determined.  On  day  4,  primary  NZB  CTL  had  a  Vi  and 
efficiency of lysis only slightly greater than that of primary BALB/c or primary DBA/ 
2 CTL, 15 :lz 2% (mean +  SEM) vs. 8.6 or 7.6% killing (Table I). The Vi and efficiency 
of lysis of secondary BALB/c and secondary NZB CTL were much greater  (Table I). 
On day 6, primary NZB, BALB/c, and DBA/2 CTL had similar Vi and efficiencies 750  HUSTON  AND  STEINBERG  BRIEF  DEFINITIVE  REPORT 
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Fro.  1.  (Left) Time-course of generation of BALB/c, DBA/2, and NZB CTL in vitro. CTL activity 
of l0  s viable effector cells was measured before and every other.day after in vitro stimulation with 
irradiated B6 spleen cells. Primary CTL  response were generated from the spleen cells of BALB/c 
(O'-Q),  DBA/2  (I---~,  and  l-mo-old  (&--&)  and  6-mo-old  (l--  _A)  NZB  mice.  Secondary 
BALB/c  (O--C))  and  secondary  NZB  (A--A)  CTL  responses  were  generated  by  the  in  vitro 
re.stimulation of spleen cells from mice B6-sensitized 14 d  previously. Effector:targaet cell ratios were 
20:1  in a  4-h S]Cr-release assay with EL-4 lymphoma target cells. Data are expressed as the mean 
percent  specific  lysis  from  triplicate  determinations,  as  described  in  Materials  and  Methods. 
Standard errors were <2% of means. 
Ft~.  2.  (Right) Plot of initial velocity oflysis by CTL from a 4-d MLC vs. target cell concentration. 
The  velocity for BALB/c  (ix), NZB  (O),  and secondary BALB/c  (O)  CTL  were determined  from 
the number of target cells killed between 30 and 90 min in a  ~Cr-release assay with labeled EL-4 
lymphoma  target  cells  and  106  effector  cells.  Velocities  at  each  target-cell  concentration  were 
obtained from data collected at three time points. 
TABLE  I 
Comparison of Kinetics of Lysis for CTL after 4 or 6 d in MLC 
Responder spleen cells* 
Initial reaction velocity:l:  Percent cells killed in initial 90 min§ 
Day 4  Day 6  Day 4  Day 6 
(No.  target cells  ×  10 -a killed/h)  '7, 
BALB/c  4.4  20.5  8.6  39 
DBA/2  4.0  20.0  7.6  38 
NZB  7.8  19.6  15  36 
Secondary BALB/c  28.6  32.5  55  62 
Secondary NZB  33.6  28.7  68  57 
* 1 ×  106 viable effector cells from a 4- or 6-d MLC were used in ~lCr-release  assay with 5 X 104 labeled EL-4 lyrnphoma 
target cells. 
:~ The number of target cells killed between 30 and 90 rain. Data were calculated as described in Materials and Methods. 
Standard errors were ~2%. 
§ The efficiency of killing by the responder spleen cells. Data were calculated as described in Materials and Methods. HUSTON  AND  STEINBERG  BRIEF  DEFINITIVE  REPORT  751 
oflysis, killing 34-39% of the target cells (Table I). The secondary NZB and secondary 
BALB/c CTL had Vi and efficiencies of lysis that were similar to each other (Table 
I) and significantly greater than that of the primary NZB, BALB/c, or DBA/2 CTL 
(60 ±  2% vs. 37 +  3%, P <  0.01).  Because primary NZB, BALB/c, and DBA/2 CTL 
had values for Vi similar to each other,  the greater killing observed with primary 
NZB CTL, compared with primary BALB/c or primary DBA/2 CTL during a  4-h 
51Cr-release assay (Fig.  1), appeared not to result from different initial kinetics of lysis. 
Therefore, a further comparison on NZB and BALB/e CTL was done with multiple- 
time-point analyses throughout  the entire 4-h  assay. Again,  their Vi  were similar. 
However, the NZB CTL maintained their Vi twice as long as did the BALB/c CTL. 
Discussion 
Primary in vitro NZB CTL responses were initially detected on the 2nd d of MLC 
and peaked on the 4th d.  In contrast, primary in vitro BALB/c and DBA/2 CTL 
responses were initially detected on the 4th d of culture and peaked on the 6th d. This 
accelerated time-course for the generation of primary in vitro NZB CTL was similar 
to that observed for secondary (i.e., in vivo primed, in vitro restimulated) NZB and 
BALB/c CTL.  Furthermore,  the spleen  cells of  1-  and  6-too-old  NZB  mice  gave 
similar primary in vitro CTL response curves. 
These observations were extended by using multiple-time-point analyses during the 
early period of 51Cr-release  assays to determine CTL kinetics of lysis. Comparison of 
the BALB/c, DBA/2, and NZB CTL kinetics of lysis demonstrated that (a) primary 
CTL responses could be easily distinguished from secondary CTL responses, and (b) 
the  CTL  generated  from  spleen  cells  of nonprimed  NZB  mice  had  hyperactive 
primary responses, not secondary responses. 
The  augmented primary immune response  observed  in  the present  study could 
have resulted from a defect in antigen nonspecific suppression, such as a defect in Ly- 
1+2+3  + feedback suppression  (5,  6).  Perhaps  the relatively normal secondary NZB 
CTL  responses  observed  herein,  reflect  normal  antigen-specific regulatory mecha- 
nisms. 
Recently, it has been reported that NZB spleen cells could generate a  primary in 
vitro CTL response against  unmodified non-NZB  targets, which were identical to 
NZB mice in the major histocompatibility complex (i.e., H-2  d)  (2, 3). This phenom- 
enon has been confirmed by others and found to be directed against Qa-1b-associated 
antigenic determinants (4) and, to a lesser extent, other minor locus determinants (U. 
Botzenhardt.  Personal  communication.).  In  normal  strains,  CTL  directed  against 
minor histocompatibility antigens are only observed in secondary immune response 
systems (7). We believe that the augmented primary CTL responses by NZB spleen 
cells in our studies could account for the apparent  unusual recognition by NZB T 
cells.  It may also explain the relative resistance of primary NZB CTL to suppressor 
signals (1),  in contrast to the total resistance of secondary CTL to such suppressor 
signals (D. P. Huston and A. D. Steinberg. Manuscript in preparation.). 
Thus, accelerated proliferation and differentiation, which characterize NZB B cells 
(8-10), also apply to NZB T  cells. The resulting augmented primary CTL response is 
analogous to the augmented primary antibody response described by Katz et al. (11). 
Such an augmented primary T  cell response may mimic secondary T  cell responses 752  HUSTON  AND  STEINBERG  BRIEF DEFINITIVE REPORT 
with regard to the recognition of minor histocompatibility antigens. Our observations 
lead  us  to suggest  that  recognition  by NZB  cells of minor antigenic  determinants 
does, in fact, not represent abnormal T  cell recognition, but, rather, accelerated CTL 
kinetics. 
Summary 
Cytotoxic lymphocyte (CTL) responses of unprimed NZB spleen cells peaked on 
day 4 of culture as did ceils from primed NZB or BALB/c mice. In contrast, primary 
BALB/c  and  DBA/2  responses  peaked  on  day  6  of culture.  Thus,  NZB  CTL 
generation was similar to the accelerated in vitro generation of CTL from the spleen 
cells of alloantigen-primed NZB and BALB/c mice. 
To evaluate the kinetics of these CTL responses, multiple-time-point analyses were 
performed during the initial 90 min of the 51Cr-release  assays. Analyses were done on 
days 4 and 6. On day 4, NZB CTL had an initial velocity of lysis slightly greater than 
that of BALB/c or DBA/2 CTL; however, it was far less than that of secondary NZB 
and secondary BALB/c CTL. 
These studies indicate that NZB mice can generate primary CTL responses at an 
accelerated rate.  Such  augmented  primary responses are  unique  and  may explain 
recently described abnormal  NZB  T  cell recognition as well  as  resistance of NZB 
CTL to suppressor signals. 
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